Abstract
Pd(II) complexes (Pd1, Pd2, and Pd3) were synthesized for the first time using asymmetric isatin bisthiocarbohydrazone ligands and PdCl2(PPh3)2. All complexes were characterized by a range of spectroscopic and analytical techniques. The molecular structures of Pd1 and Pd3 have been determined by single-crystal X-ray diffraction analysis. The complexes are diamagnetic and exhibit square planar geometry. The asymmetric isatin bisthiocarbohydrazone ligands coordinate to Pd(II) ion in a tridentate manner, through the phenolic oxygen, imine nitrogen and thiol sulfur, forming five- and six-membered chelate rings within their structures. The fourth coordination site in these complexes is occupied by PPh3 (triphenylphosphine). The free ligands and their Pd(II) complexes were evaluated for their carbonic anhydrase I, II (hCAs) and acetylcholinesterase (AChE) inhibitor activities. They showed a highly potent inhibition effect on AChE and hCAs. Ki values are in the range of 9 ± 0.6 – 30 ± 5.4 nM for AChE, 7 ± 0.5 – 16 ± 2.2 nM for hCA I and 3 ± 0.3–24 ± 1.9 nM for hCA II isoenzyme. The results clearly demonstrated that the ligands and their Pd(II) complexes effectively inhibited the used enzymes.
Graphical abstract
Similar content being viewed by others
References
Medvedev A, Buneeva O, Glover V (2007) Biol Targets Ther 1:151–162
Ozgun DO, Yamali C, Gul HI, Taslimi P, Gulcin I, Yanik T, Supuran CT (2016) J Enzyme Inhib Med Chem 31:1498–1501
Zhang YZ, Du HZ, Liu HL, He QS, Xu Z (2020) Arch Pharm 353:e1900299
Imada C (2004) Mar Biotechnol 6:193–198
Sonawane RP, Tripathi RR (2013) Int Lett Chem Phys Astron 7:30–36
Borad MA, Bhoi MN, Prajapati NP, Patel HD (2014) Synth Commun 44:897–922
Kumar SLA, Kumar MS, Jenniefer SJ, Muthiah PT, Sreekanth A (2013) Phosphorus Sulfur Silicon Relat Elem 188:1110–1118
Zafarian H, Sedaghat T, Motamedi H, Rudbari HA (2016) J Organomet Chem 825–826:25–32
Sathisha MP, Shetti UN, Revankar VK, Pai KSR (2008) Eur J Med Chem 43:2338–2346
Bonaccorso C, Grasso G, Musso N, Barresi V, Condorelli DF, La Mendola D, Rizzarelli E (2018) J Inorg Biochem 182:92–102
Metwally MA, Khalifa ME, Koketsu M (2012) Am J Chem 2:38–51
Bonaccorso C, Marzo T, La Mendola D (2020) Pharmaceuticals 13:1–19
Juranić Z, Anastasova F, Juranić I, Stanojković T, Radulović S, Vuletić N (1999) J Exp Clin Cancer Res 18:317–324
Gabr MT, El-Gohary NS, El-Bendary ER, El-Kerdawy MM, Ni N (2017) Eur J Med Chem 128:36–44
Sathisha MP, Revankar VK, Pai KSR (2008) Met Based Drugs 2008:1–11
Marques MPM (2013) Int Sch Res Not 2013:1–29
Özerkan D, Ertik O, Kaya B, Kuruca SE, Yanardag R, Ülküseven B (2019) Investig New Drugs 37:1187–1197
Bjelogrlić SK, Todorović TR, Kojić M, Senćanski M, Nikolić M, Višnjevac A, Araškov J, Miljković M, Muller CD, Filipović NR (2019) J Inorg Biochem 199:110758
Muche S, Harms K, Biernasiuk A, Malm A, Popiołek Ł, Hordyjewska A, Olszewska A, Hołyńska M (2018) Polyhedron 151:465–477
Shaheen F, Badshah A, Gielen M, Gieck C, Jamil M, de Vos D (2008) J Organomet Chem 693:1117–1126
Gaber M, El-Ghamry HA, Fathalla SK (2015) Spectrochim Acta A Mol Biomol Spectrosc 139:396–404
Rocha FV, Farias RL, Lima MA, Batista VS, Nascimento-Junior NM, Garrido SS, Leopoldino AM, Goto RN, Oliveira AB, Beck J (2019) J Inorg Biochem 199:110725
Rocha FV, Barra CV, Garrido SS, Manente FA, Carlos IZ, Ellena J, Fuentes ASC, Gautier A, Morel L, Mauro AE, Netto AVG (2016) J Inorg Biochem 159:165–168
Mitoraj MP, Michalak A (2010) Inorg Chem 49:578–582
Elsayed SA, Badr HE, di Biase A, El-Hendawy AM (2021) J Inorg Biochem 223:111549
Sağlık BN, Çevik UA, Osmaniye D, Levent S, Çavuşoğlu BK, Demir Y, Ilgın S, Özkay Y, Koparal AS, Beydemir Ş, Kaplancıklı ZA (2019) Bioorg Chem 91:103153
Caglayan C, Taslimi P, Türk C, Gulcin İ, Kandemir FM, Demir Y, Beydemir Ş (2020) Environ Sci Pollut Res 27:10607–10616
Hoff E, Zou D, Schiza S, Demir Y, Grote L, Bouloukaki I, Beydemir Ş, Eskandari D, Stenlöf K, Hedner J (2020) J Sleep Res 29:e12956
Bilginer S, Anıl B, Koca M, Demir Y, Gülçin İ (2021) Turk J Chem 45:805–818
Nar M, Çetinkaya Y, Gülçin İ, Menzek A (2013) J Enzyme Inhib Med Chem 28:402–406
Özbey F, Taslimi P, Gülçin İ, Maraş A, Göksu S, Supuran CT (2016) J Enzyme Inhib Med Chem 31:79–85
Kucuk M, Gulcin İ (2016) Environ Toxicol Pharmacol 44:134–139
Istrefi Q, Türkeş C, Arslan M, Demir Y, Nixha AR, Beydemir Ş, Küfrevioğlu Öİ (2020) Arch Pharm 353:e1900383
Tugrak M, Gul HI, Demir Y, Levent S, Gulcin I (2021) Arch Pharm 354:e2000375
Yamali C, Gul HI, Cakir T, Demir Y, Gulcin I (2020) Lett Drug Des Discov 17:1283–1292
Erdemir F, Celepci DB, Aktaş A, Taslimi P, Gök Y, Karabıyık H, Gülçin İ (2018) J Mol Struct 1155:797–806
Yamali C, Gül Hİ, Demir Y, Kazaz C, Gülçin İ (2020) Turk J Chem 44:1058–1067
Gülçin İ, Scozzafava A, Supuran CT, Koksal Z, Turkan F, Çetinkaya S, Bingöl Z, Huyut Z, Alwasel SH (2016) J Enzyme Inhib Med Chem 31:1698–1702
Bayrak C, Taslimi P, Karaman HS, Gulcin I, Menzek A (2019) Bioorg Chem 85:128–139
Günsel A, Taslimi P, Atmaca GY, Bilgiçli AT, Pişkin H, Ceylan Y, Erdoğmuş A, Yarasir MN, Gülçin İ (2021) J Mol Struct 1237:130402
Erdoğan M, Polat Köse L, Eşsiz S, Gülçin İ (2021) Arch Pharm 354:e2100113
Eruygur N, Koçyiğit UM, Taslimi P, Ataş M, Tekin M, Gülçin İ (2019) S Afr J Bot 120:141–145
Burmaoglu S, Yilmaz AO, Polat MF, Kaya R, Gulcin İ, Algul O (2019) Bioorg Chem 85:191–197
Yamali C, Gul HI, Ece A, Taslimi P, Gulcin I (2018) Chem Biol Drug Des 91:854–866
Kaya Y, Erçağ A, Uğuz Ö, Koca A, Zorlu Y, Hacıoğlu M, Tan ASB (2021) Polyhedron 207:115372
Burns GR (1968) Inorg Chem 7:277–283
Bruker (2014) APEX2, version 201411-0. Bruker AXS Inc, Madison
Bruker (2013) SAINT, version 834 A. Bruker AXS Inc, Madison
Bruker (2014) SADABS, version 2014/5. Bruker AXS Inc, Madison
Sheldrick GM (2015) Acta Crystallogr Sect A Found Adv 71:3–8
Sheldrick GM (2015) Acta Crystallogr Sect C Struct Chem 71:3–8
Dolomanov OV, Bourhis LJ, Gildea RJ, Howard JAK, Puschmann H (2009) J Appl Crystallogr 42:339–341
Spek AL (2009) Acta Crystallogr Sect D Biol Crystallogr 65:148–155
Macrae CF, Sovago I, Cottrell SJ, Galek PTA, McCabe P, Pidcock E, Platings M, Shields GP, Stevens JS, Towler M (2020) J Appl Crystallogr 53:226–235
Verpoorte JA, Mehta S, Edsall JT (1967) J Biol Chem 242:4221–4229
Huseynova M, Taslimi P, Medjidov A, Farzaliyev V, Aliyeva M, Gondolova G, Şahin O, Yalçın B, Sujayev A, Orman EB, Özkaya AR, Gulçin İ (2018) Polyhedron 155:25–33
Biçer A, Taslimi P, Yakalı G, Gülçin I, Gültekin MS, Cin GT (2019) Bioorg Chem 82:393–404
Akıncıoğlu A, Göksu S, Naderi A, Akıncıoğlu H, Kılınç N, Gülçin İ (2021) Comput Biol Chem 94:107565
Taslimi P, Caglayan C, Gulcin İ (2017) J Biochem Mol Toxicol 31:e21995
Scozzafava A, Kalın P, Supuran CT, Gülçin İ, Alwasel SH (2015) J Enzyme Inhib Med Chem 30:941–946
Ellman GL, Courtney KD, Andres V Jr, Featherstone RM (1961) Biochem Pharmacol 7:88–95
Turan B, Şendil K, Şengül E, Gültekin MS, Taslimi P, Gulcin I, Supuran CT (2016) J Enzyme Inhib Med Chem 31:79–88
Erdemir F, Celepci DB, Aktaş A, Gök Y, Kaya R, Taslimi P, Demir Y, Gulçin İ (2019) Bioorg Chem 91:103134
Pedrood K, Sherafati M, Mohammadi-Khanaposhtani M, Asgari MS, Hosseini S, Rastegar H, Larijani B, Mahdavi M, Taslimi P, Erden Y, Günay S, Gulçin İ (2021) Int J Biol Macromol 170:1–12
Demir Y, Duran HE, Durmaz L, Taslimi P, Beydemir Ş, Gulçin İ (2020) Appl Biochem Biotechnol 190:437–447
Demir Y, Taslimi P, Koçyiğit ÜM, Akkuş M, Özaslan MS, Duran HE, Budak Y, Tüzün B, Gürdere MB, Ceylan M, Taysi S, Gülçin İ, Beydemir Ş (2020) Arch Pharm 353:e2000118
Taslimi P, Akıncıoglu H and Gülçin İ (2017) J Biochem Mol Toxicol 31:e21973
Taslimi P, Gülçin İ, Öztaşkın N, Cetinkaya Y, Göksu S, Alwasel SH, Supuran CT (2016) J Enzyme Inhib Med Chem 31:603–607
Topal F, Gulcin I, Dastan A, Guney M (2017) Int J Biol Macromol 94:845–851
Gulcin İ, Alwasel SH (2022) Processes 10:132
Demir Y, Taslimi P, Ozaslan MS, Oztaskin N, Çetinkaya Y, Gulçin İ, Beydemir Ş, Goksu S (2018) Arch Pharm 351:e1800263
Demir Y, Işık M, Gülçin İ, Beydemir Ş (2017) Impact of HIV infection and HAART on serum lipids in men. J Biochem Mol Toxicol 31:e21936
Sujayev A, Garibov E, Taslimi P, Gulçin İ, Gojayeva S, Farzaliyev V, Alwasel SH, Supuran CT (2016) J Enzyme Inhib Med Chem 31:1531–1539
Ali OAM (2014) Spectrochim Acta A Mol Biomol Spectrosc 121:188–195
Geary WJ (1971) Coord Chem Rev 7:81–122
Abouzayed FI, Emam SM, Abouel-Enein SA (2020) J Mol Struct 1216:128314
Gray HB, Ballhausen CJ (1963) J Am Chem Soc 85:260–265
Yakan H, Bakır TK, Çavuş MS, Muğlu H (2020) Res Chem Intermed 46:5417–5440
Eğlence-Bakır S, Şahin M, Salt BZ, Tüzün E, Kara EM, Atun G, Çavuş S, Kızılcıklı İ (2020) Spectrochim Acta A Mol Biomol Spectrosc 237:118358
Bacchi A, Carcelli M, Pelagatti P, Pelizzi G, Rodriguez-Arguelles MC, Rogolino D, Solinas C, Zani F (2005) J Inorg Biochem 99:397–408
Gangarapu K, Manda S, Jallapally A, Thota S, Karki SS, Balzarini J, De Clercq E, Tokuda H (2014) Med Chem Res 23:1046–1056
Shabbir M, Akhter Z, Ashraf AR, Ismail H, Habib A, Mirza B (2017) J Mol Struct 1149:720–726
Shabbir M, Akhter Z, Ahmad I, Ahmed S, Shafiq M, Mirza B, McKee V, Munawar KS, Ashraf AR (2016) J Mol Struct 1118:250–258
Ayyannan G, Mohanraj M, Gopiraman M, Uthayamalar R, Raja G, Bhuvanesh N, Nandhakumar R, Jayabalakrishnan C (2020) Impact of HIV infection and HAART on serum lipids in men. Inorg Chim Acta 512:119868
Muralisankar M, Sujith S, Bhuvanesh NSP, Sreekanth A (2016) Polyhedron 118:103–117
Yang L, Powell DR and Houser RP (2007) Dalton Trans 9: 955–964
Halder S, Peng S-M, Lee G-H, Chatterjee T, Mukherjee A, Dutta S, Sanyal U, Bhattacharya S (2008) New J Chem 32:105–114
Ramachandran E, Raja DS, Bhuvanesh NSP, Natarajan K (2012) Dalton Trans 41:13308–13323
Kalaivani P, Prabhakaran R, Dallemer F, Poornima P, Vaishnavi E, Ramachandran E, Padma VV, Renganathan R, Natarajan K (2012) Metallomics 4:101–113
Prabhakaran R, Renukadevi SV, Karvembu R, Huang R, Mautz J, Huttner G, Subashkumar R, Natarajan K (2008) Eur J Med Chem 43:268–273
Prabhakaran R, Palaniappan K, Huang R, Sieger M, Kaim W, Viswanathamurthi P, Dallemer F, Natarajan K (2011) Inorg Chim Acta 376:317–324
Topal M, Gocer H, Topal F, Kalin P, Köse LP, Gülçin İ, Cakmak KC, Küçük M, Durmaz L, Gören AC, Alwasel SH (2016) J Enzyme Inhib Med Chem 31:266–275
Gulçin İ, Taslimi P, Aygün A, Sadeghian N, Bastem E, Kufrevioglu OI, Turkan F, Şen F (2018) Int J Biol Macromol 119:741–746
Acknowledgements
This work was supported by the Scientific Research Projects Coordination Unit of Istanbul University-Cerrahpaşa (Project Number FBA-2017-25859).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kaya, Y., Erçağ, A., Zorlu, Y. et al. New Pd(II) complexes of the bisthiocarbohydrazones derived from isatin and disubstituted salicylaldehydes: Synthesis, characterization, crystal structures and inhibitory properties against some metabolic enzymes. J Biol Inorg Chem 27, 271–281 (2022). https://doi.org/10.1007/s00775-022-01932-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-022-01932-9